Similarly, markers of metabolic disorders are considered to have a prognostic information for the severity of CVDs, such as the lipid profile, vitamin D, fetuin-A, and diabetes-related biomarkers of, for example, blood glucose and haemoglobinA1c levels. This evidence concerns the gene AHSG and metabolic disease.